Fujifilm’s biomanufacturing facility is located in the Research Triangle Park in North Carolina, close to Morrisville and Cary communities. Contact us to update your basic listing. It aims for the business to achieve a sales target of JPY100bn ($919.4m) by March 2024. The company offers a comprehensive list of services from cell line development using its proprietary pAVEway™ microbial and Apollo™X cell line systems to process development, analytical development, clinical and FDA-approved commercial manufacturing. The expansion will add 2,000l single-use cell culture manufacturing trains to the state-of-the-art three-storey, 62,000ft² North Carolina facility. The project is part of Fujifilm’s JPY10bn ($90m) investment plan announced in January 2019 to expand its biotechnology CDMO business. It was developed by a collaboration of universities, companies and the government to support research and development (R&D) in North Carolina. FUJIFILM Diosynth Biotechnologies announced on July 23 an agreement with Novavax, Inc. to manufacture bulk drug substance for NVX-CoV2373 at its site in Morrisville, North Carolina. The single-use bioreactors are stirred tank bioreactors for scalable and robust performance in both current good manufacturing practice (cGMP) and non-cGMP conditions. The technology transfer from North Carolina to Texas will begin in late 2020 with expanded mass production of the vaccine candidate starting in early 2021. “Our leading scientists and engineers in College Station are honored to support COVID-19 vaccine manufacturing with the goal of delivering a safe and effective vaccine to the U.S. population,” said Dr. Gerry Farrell, chief operating officer, FUJIFILM Diosynth Biotechnologies, Texas. Besides the BioProcess Innovation Center in North Carolina, the company is also located in College Station, Texas, US, as well as Billingham and Redcar in the UK. You may reproduce the NCBiotech Company Directory site content for any legal purpose with proper attribution. On Monday, Trump will visit the FUJIFILM Diosynth Biotechnologies' Innovation Center in Morrisville. For more information, please visit www.fujifilmdiosynth.com, About FUJIFILM
The NCBiotech Company Directory is maintained by, Therapeutics - Large Molecule (biologics). www.fujifilmdiosynth.com. GE Healthcare’s Xcellerex single-use bioreactors installed at the facility are beneficial for biologics production due to low capital requirement, operational cost and environmental footprint. By using the site you are agreeing to our Privacy Policy. Gaithersburg, MD and Morrisville, NC – Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, and FUJIFILM Diosynth Biotechnologies (FDB), a world leading contract development and manufacturing organization (CDMO) for biologics, viral vaccines and gene therapies, announced today an agreement … Cary, NC 27513 . For more information, please visit: www.fujifilmholdings.com. The platform complements the company’s pAVEway™ microbial system, which is utilised for efficient microbial protein expression. The Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, issued a task order through the Texas A&M System (TAMUS) Center for Innovation in Advanced Development & Manufacturing (CIADM). Fujifilm Diosynth Biotechnologies is an industry leading Biologics Contract Development and Manufacturing Organization with locations in Research Triangle Park, North Carolina and Billingham, United Kingdom. It will also add cell culture purification capabilities and new microbial recovery capabilities to the facility. Fujifilm Diosynth Biotechnologies provides biologics contract development and manufacturing. The pAVEway™ system is based on unique modified E.coli vectors for high-level expression of proteins. The technology transfer from North Carolina to Texas will begin in late 2020 with expanded mass production of the vaccine candidate starting in early 2021. The project will improve the facility’s manufacturing capacity for cell cultures by 25% and microbial systems by 50%. Fujifilm Corporation is a wholly-owned subsidiary of Fujifilm Holdings Corporation. The bioreactors can function in batch, fed-batch and perfusion bioreactor modes depending upon the requirement. To enhance vaccine production, the task order will help FUJIFILM Diosynth Biotechnologies accelerate its planned capacity expansion investments in the FBF by several months, now with an anticipated completion by fall 2020. FUJIFILM Diosynth Biotechnologies is an industry-leading Biologics Contract Development and Manufacturing Organization (CDMO) with locations in Teesside, UK, RTP, North Carolina, College Station, Texas and Hillerød, Denmark. The park is one of the biggest research and science parks in the US. MORRISVILLE, N.C. (WTVD) -- President Donald Trump will be visiting Wake County next week. Its proprietary core technologies contribute to the various fields including healthcare, graphic systems, highly functional materials, optical devices, digital imaging and document products. For the year ended March 31, 2020, the company had global revenues of $21 billion, at an exchange rate of 109 yen to the dollar. The bioreactors are suitable for multi-product contract manufacturing with the advantage of easy expansion to meet increased demand and can flexibly manufacture products for pre-clinical and clinical studies. Spanning approximately 7,000 acres, the Research Triangle Park is situated close to the cities of Raleigh, Durham and Chapel Hill. “We will allocate the reserved capacity based on direction provided by the U.S. government, and similar to our North Carolina site, we expect a portion of the reserved capacity to be allocated to Novavax, Inc. for its NVX-CoV2373 COVID-19 vaccine candidate.”. This website uses cookies. All rights reserved. 3000 Weston Parkway. FUJIFILM Diosynth Biotechnologies has over thirty years of experience in the development and manufacturing of recombinant proteins, vaccines, monoclonal antibodies, among other large molecules, viral products and medical countermeasures expressed in a wide array of microbial, mammalian, and host/virus systems. Reviews (919) 337-4400 Website. College Station, Texas, July 27, 2020 — FUJIFILM Diosynth Biotechnologies, a world leading contract development and manufacturing organization (CDMO) for biologics, viral vaccines and gene therapies, announced today that its College Station, Texas, site will support COVID-19 vaccine candidate manufacturing, as part of Operation Warp Speed, a U.S. government program that aims to begin delivering millions of doses of a safe, effective vaccine for COVID-19 to the U.S. population. FUJIFILM Diosynth Biotechnologies Texas Facility to Support COVID-19 Vaccine Candidate Manufacturing.